Takeda Pharmaceuticals Wins Recent Pharmaceutical Liability Case

Understanding pharmaceutical liability laws are important to protect both patients and companies that manufacture drugs to improve lives. The largest drug manufacturer in Asia, Takeda Pharmaceutical Co., recently won a lawsuit related to its Actos diabetes medication. The company is facing thousands of similar lawsuits throughout the United States. In the latest case, the company was found not liable for causing the bladder cancer of two women. The jury found that the company's drug did not cause bladder cancer. The finding is the company's fifth victory out of six similar cases that have gone to trial in the United States.

Eli Lilly and Co., which marketed the drug for Takeda in the United States was not named in this lawsuit, though it has been named in others. Recently, as mentioned in this blog, Takeda and Lilly were ordered to pay over $9 billion to one litigant with bladder cancer who had taken the drug. Takeda, which has indemnified Lilly, plans to appeal the verdict and damages award.

Takeda is accused of failing to properly warn users of the drug of the possible increased risk of bladder cancer and heart problems reported in an analysis of the drug performed by the Food and Drug Administration in 2011. Lawyers for Takeda argue that the women who developed bladder cancer could not prove it was the drug that caused it, as they were not currently taking the drug when diagnosed.

Pharmaceutical companies face the prospect of drug liability and pharmaceutical liability lawsuits on a daily basis. When a lawsuit is brought, often every party in the chain of distribution, from pharmaceutical marketing firms to drug manufacturers to prescribing physicians, can face liability for harm that results from a patient injury. Because of this, it is important for companies that are engaged in the pharmaceuticals business to understand how to effectively mitigate risk and confront unwarranted claims for damages.

While no one wants patients to suffer from defective or harmful drugs, pharmaceutical development requires extensive resources to develop life-saving medications. Because of this, it is important for pharmaceutical companies to understand how to protect themselves and preserve essential resources when necessary.

    Lyons & Simmons quickly became the glue that held our family together.

    “Lyons & Simmons quickly became the glue that held our family together.”

    - Kelsy
    Staff Was Exceptional & Professional

    “They handled my case with such professionalism that I was very much at ease. I didn’t feel like just a case number or just another client. They were very family oriented which made me feel that they put my family first.”

    - Dianna W.
    Instrumental in Resolving Matters!

    “Michael Lyons, Chris Simmons, and the entire team at Lyons & Simmons have been instrumental in resolving matters over the years with the utmost expertise, professionalism, responsiveness, and care leading to results in my best interest.”

    - Cade M.
    We Are Forever Grateful!

    “Mike Lyons and his team were amazing to work with! He brought us such a great amount of hope in the midst of a difficult situation.”

    - Chelsie H.
    Brilliant Strategist and a Fearless Fighter for Justice

    “Mr. Lyons's predictions regarding the outcome of my case and the timeline were spot on. I was never misled or put on the back burner. He always responded to my questions in a very clear and honest way. He comes highly recommended!”

    - Amy B.

Let Us Make A Difference

Lyons & Simmons Is Here to Help

When you have been injured, every second counts. Speak with one of our nationwide trial attorneys today.

  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.